在炎症性皮肤疾病和相关治疗方法中,组织组织蛋白修饰的Noval提前
Lichen Zhang1,2, Rongrong Chai1,2, Zongguang Tai1,2
1Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China.
Frontiers in immunology
|January 18, 2024
概括
基因表观遗传过程 - - 基因基因基因基因基因的修饰,是长期炎症性皮肤疾病 (如牛皮) 的关键. 针对这些修改提供了新的治疗途径,以改善患者的治疗结果.
科学领域:
- 皮肤病学 皮肤病学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 慢性炎症性皮肤疾病源于免疫系统功能障碍影响皮肤组织.
- 基因组蛋白修饰是一种关键的表观遗传机制,参与了这些疾病的发展和治疗.
- 这些疾病包括牛皮,亚托邦性皮肤炎,狼,全身性硬化症,接触性皮肤炎,平状和白.
研究的目的:
- 为了提供一个全面的概述的基因素修饰类型.
- 阐明基因组修饰与慢性炎症性皮肤疾病之间的关联.
- 审查当前和潜在的治疗策略,以向激素修饰.
主要方法:
- 关于基因素修饰类型及其在皮肤疾病中的作用的文献综述.
- 通过基因组修饰进行表观遗传调节与疾病发病之间的联系的分析.
- 对治疗干预措施的检查重点是调节质子修饰.
主要成果:
- 基因组蛋白修饰包含了对基因调节至关重要的多种机制.
- 特定的组织蛋白修饰和各种慢性炎症性皮肤疾病的发病之间存在强烈的相关性.
- 向激素修饰是一种有前途的治疗策略.
结论:
- 了解组织蛋白修饰对于促进炎症性皮肤疾病的管理至关重要.
- 调节质子修饰提供了新和有效治疗的潜力.
- 进一步研究基因组修饰将推动创新,并改善皮肤病患者的治疗结果.
相关概念视频
Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
139
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
139
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Spreading of Chromatin Modifications
8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.3K


